Document is current
Any future updates will be listed below
-
Authors
Heitmann, Jonas S.
Bilich, Tatjana http://orcid.org/0000-0002-8107-0419
Tandler, Claudia
Nelde, Annika http://orcid.org/0000-0001-8504-8481
Maringer, Yacine http://orcid.org/0000-0002-2197-8740
Marconato, Maddalena
Reusch, Julia
Jäger, Simon
Denk, Monika
Richter, Marion
Anton, Leonard
Weber, Lisa Marie http://orcid.org/0000-0001-9514-5218
Roerden, Malte http://orcid.org/0000-0001-7283-9778
Bauer, Jens http://orcid.org/0000-0003-3731-2385
Rieth, Jonas
Wacker, Marcel
Hörber, Sebastian http://orcid.org/0000-0002-5718-1530
Peter, Andreas
Meisner, Christoph
Fischer, Imma
Löffler, Markus W.
Karbach, Julia
Jäger, Elke
Klein, Reinhild
Rammensee, Hans-Georg
Salih, Helmut R. http://orcid.org/0000-0002-6719-1847
Walz, Juliane S. http://orcid.org/0000-0001-6404-7391
- License Information
-
More Information
Article History
Received: 17 August 2021
Accepted: 11 November 2021
First Online: 23 November 2021
Competing interests
: The University Hospital Tübingen is in the process of applying for a patent application (EP 20 169 047.6) covering the SARS-CoV-2 T cell epitopes included in CoVac-1 that lists A.N., T.B., H.-G.R. and J.S.W as inventors. EMC Microcollections GmbH is in the process of applying for a patent application (DE102016005550.2) covering the adjuvant XS15 included in CoVac-1 that lists H.-G.R. as an inventor. The other authors declare no competing interests.
